A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 900 participants.
Also called NCT07230730
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 900 participants
- Registry
-
NCT07230730
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07230730. Randomized; quadruple masking; primary purpose treatment. Start 2026-01-13 (actual); primary completion 2027-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
- Condition
- Hyperlipidemia
- Intervention (Drug)
- SHR-1918
- Intervention (Drug)
- SHR-1918 placebo
- Lead sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd
Record details
- Record id
cardio:ct-nct07230730- Content hash
94a5c055bef680d4ac6b4061ee8b236cf9146b8a3565d6f8b662e9229868436e